Queensland Renal Biopsy Registry Sub Study: Multi-centre prospective observational cohort study investigating association between anti-neutrophil cytoplasmic antibodies (ANCA) results and relapse of ANCA associated vasculitis
Multi-centre prospective observational cohort study investigating association between anti-neutrophil cytoplasmic antibodies (ANCA) results and relapse of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis
Dr Dwarakanathan Ranganathan
109 participants
May 13, 2021
Observational
Conditions
Summary
This prospective study will monitor ANCA levels in patients with ANCA vasculitis. The purpose of this study is to Identify if ANCA rises are associated with relapse of ANCA vasculitis. Study hypothesis: two and four-fold ANCA rises will precede clinical relapses within the prior 6 months
Eligibility
Inclusion Criteria2
- Patients with ANCA vasculitis based on compatible serology, radiology, histology and/or biochemistry.
- Participants need to have been enrolled into the Queensland Renal Biopsy Registry
Exclusion Criteria1
- ANCA negative vasculitis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
3 monthly assessments for at least 3 years. Monitoring association between ANCA levels and disease activity / relapse. - No alteration to patient standard medical care - However, patient medical records will be accessed - long-term (many years) 3 monthly follow up will be required for disease management irrespective of enrolment in trial
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12622000012774